| 2.12 Delayed Data As of 3:59pm ET |  +0.02 / +0.95%Today’s Change | 1.88 Today|||52-Week Range 7.57 | -24.82% Year-to-Date |
| The Top 5 Marijuana Investing Mistakes to Avoid Jun 17 / MotleyFool.comFOO - Paid Partner Content | After Illinois, These States Could Legalize Recreational Marijuana Next Jun 09 / MotleyFool.comFOO - Paid Partner Content |
| 3 Popular Pot Stocks That Won't Be Profitable in 2020 Jun 13 / MotleyFool.comFOO - Paid Partner Content | 3 Pot Stocks to Avoid Like the Plague in June Jun 06 / MotleyFool.comFOO - Paid Partner Content |
| 3 U.S. Pot Stocks Wall Street Expects Will Double Jun 10 / MotleyFool.comFOO - Paid Partner Content |
| Previous close | 2.10 |
| Today’s open | 2.12 |
| Day’s range | 2.10 - 2.21 |
| Volume | 942,275 |
| Average volume (3 months) | 1,280,757 |
| Market cap | $1.0B |
| Earnings growth (last year) | -675.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +2,067,803.02% |
| P/E ratio | -- |
| Price/Sales | 0.97 |
| Price/Book | 0.82 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $39.8M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -167.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Adam Bierman |
President & Director Andrew Modlin |
Corporate headquarters Culver City, California |
